Browsing: Smart Trends

These three growth stocks can provide rocket fuel for your portfolio’s growth.

Retail is always evolving as it is a fast-changing industry. Here are three retail trends that investors should take note of this year.

Will the REIT sector fare well this year after the unprecedented stress it faced last year? Let’s find out.

An introduction to sustainable investing and company sustainability ratings, and what these mean for investors.

Hong Kong’s main index is set to undergo major changes.

Advertising tech giants, Facebook and Google, are facing increasing competition even as they battle antitrust allegations. Here are 3 companies that are giving them a run for their money.

If you’re looking for growth this year, look no farther than these three stocks.

Some might criticise multi-billionaire Musk for biting off more than he can chew and having his finger in too many pies.

We take a quick look at what this year has brought us.

A closer look at the biggest components of this exciting new ETF.

Will investors wake up to a Christmas rally brought about by increased optimism over the end of the pandemic?

Will travel and tourism stocks fly high in 2021?

Even amid a crisis, these three companies have found suitable acquisitions to grow their business further.

Here are three things you can expect when Singapore enters Phase III of its reopening.

The move highlights the growing importance of digital assets and currencies.

As the adoption of cryptocurrencies becomes more mainstream, here are 3 growth stocks that will profit from the trend.

The healthcare glove manufacturer continues to announce amazing numbers.

Investors may be worried about impending competition from Singapore’s new digital banks. We find out if the local banks are still worth investing in.

The Monetary Authority of Singapore has announced the award of four digital bank licences. What are the investment implications?

Moderna and BioNTech’s share prices have increased by 621% and 237% year-to-date. Is it too late to get in on these COVID-19 vaccine frontrunners?